Mark Neilly

Papers

Total Citations

H-Index

About

Mark Neilly is a prominent figure in thoracic oncology, with his research primarily focused on advancing the understanding and treatment of lung cancer, the leading cause of cancer-related death worldwide. His major contributions center on synthesizing and disseminating cutting-edge developments from major international congresses, most notably through his work with the European Respiratory Society (ERS). His highly cited paper, "ERS Congress 2024: highlights from the Thoracic Oncology Assembly," which has already garnered 2 citations shortly after publication, distills the most impactful findings presented at the 2024 ERS Congress in Vienna, Austria. This work serves as a critical resource for clinicians and researchers, translating complex global expert discussions into actionable insights for improving patient outcomes. By bridging the gap between high-level conference data and clinical practice, Neilly’s research helps alleviate the significant pressure thoracic malignancies place on healthcare systems. His ability to identify and communicate pivotal advancements in diagnostics, therapeutics, and management strategies underscores his role as a key communicator and thought leader in the field, making his summaries essential reading for anyone tracking the rapid evolution of lung cancer care.